Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Jörg Ruof"'
Autor:
Francine Brinkhuis, Elaine Julian, Hendrika van den Ham, Fabrizio Gianfrate, Valentina Strammiello, Michael Berntgen, Mira Pavlovic, Peter Mol, Jürgen Wasem, Walter Van Dyck, Antonella Cardone, Christian Dierks, Anja Schiel, Renato Bernardini, Oriol Solà-Morales, Jörg Ruof, Wim Goettsch
Publikováno v:
Health Research Policy and Systems, Vol 22, Iss 1, Pp 1-12 (2024)
Abstract Background The European Regulation on Health Technology Assessment (EU HTA R), effective since January 2022, aims to harmonize and improve the efficiency of common HTA across Member States (MS), with a phased implementation from January 2025
Externí odkaz:
https://doaj.org/article/660c1c179a5f4b32bace34cbb01905ab
Autor:
Elaine Julian, Oriol Solà-Morales, Maria João Garcia, Francine Brinkhuis, Mira Pavlovic, Carlos Martín-Saborido, Robin Doeswijk, Rosa Giuliani, Anne Willemsen, Wim Goettsch, Bernhard Wörmann, Urania Dafni, Heiner C. Bucher, Begoña Pérez-Valderrama, Renato Bernardini, Fabrizio Gianfrate, Carin A. Uyl-de Groot, Jörg Ruof
Publikováno v:
Journal of Market Access & Health Policy, Vol 12, Iss 3, Pp 128-143 (2024)
Background: This work aimed to determine the role and action points for the involvement of medical societies in the European Health Technology Assessment (EU HTA) Methods: An online pre-convention survey was developed addressing four areas related to
Externí odkaz:
https://doaj.org/article/f7baa0ed8a53416196beab87cb2d5619
Autor:
Thomas Desmet, Elaine Julian, Walter Van Dyck, Isabelle Huys, Steven Simoens, Rosa Giuliani, Mondher Toumi, Christian Dierks, Juliana Dierks, Antonella Cardone, Francois Houÿez, Mira Pavlovic, Michael Berntgen, Peter Mol, Anja Schiel, Wim Goettsch, Fabrizio Gianfrate, Stefano Capri, James Ryan, Pierre Ducournau, Oriol Solà-Morales, Jörg Ruof
Publikováno v:
Journal of Market Access & Health Policy, Vol 12, Iss 1, Pp 21-34 (2024)
Objectives: Stakeholder involvement has long been considered a success factor for a joint European health technology assessment (HTA) process, and its relevance is now anchored in the EU HTA Regulation’s (EU HTAR) legislative wording. Therefore, we
Externí odkaz:
https://doaj.org/article/7f514bab01674db19ecb4093613aaea7
Autor:
Lauren Van Haesendonck, Jörg Ruof, Thomas Desmet, Walter Van Dyck, Steven Simoens, Isabelle Huys, Rosa Giuliani, Mondher Toumi, Christian Dierks, Juliana Dierks, Antonella Cardone, Francois Houÿez, Mira Pavlovic, Michael Berntgen, Peter G.M. Mol, Anja Schiel, Wim Goettsch, Fabrizio Gianfrate, Stefano Capri, James Ryan, Pierre Ducournau, Oriol Solà-Morales, Elaine Julian
Publikováno v:
Journal of Market Access & Health Policy, Vol 11, Iss 1 (2023)
ABSTRACTInvolvement of all relevant stakeholders will be of utmost importance for the success of the developing EU HTA harmonization process.A multi-step procedure was applied to develop a survey across stakeholders/collaborators within the EU HTA fr
Externí odkaz:
https://doaj.org/article/b464df9353d045aaaaa896a7a0f4680a
Autor:
Elaine Julian, Mira Pavlovic, Oriol Sola-Morales, Fabrizio Gianfrate, Mondher Toumi, Heiner C. Bucher, Christian Dierks, Wolfgang Greiner, Peter Mol, Jean-François Bergmann, Tomas Salmonson, Ansgar Hebborn, Mathilde Grande, Antonella Cardone, Jörg Ruof
Publikováno v:
Health Economics Review, Vol 12, Iss 1, Pp 1-15 (2022)
Abstract Objectives Key challenges for a joint European Health Technology Assessment (HTA) include consolidated approaches towards the choice of adequate comparator(s), selection of endpoints that are relevant to patients with a given disease, dealin
Externí odkaz:
https://doaj.org/article/49b7e3fc8c3140c6be0c21e052b00350
Autor:
Elaine Julian, Fabrizio Gianfrate, Oriol Sola-Morales, Peter Mol, Jean-François Bergmann, Tomas Salmonson, Ansgar Hebborn, Mathilde Grande, Jörg Ruof
Publikováno v:
Health Economics Review, Vol 12, Iss 1, Pp 1-12 (2022)
Abstract Objectives We conducted a multi-stakeholder survey to determine key areas where a joint European health technology assessment (HTA) could provide ‘additional benefit’ compared to the status quo of many parallel independent national and s
Externí odkaz:
https://doaj.org/article/2ba07948754a4eed9306acaeee9a8759
Autor:
Thomas R. Staab, Miriam Walter, Sonja Mariotti Nesurini, Charalabos-Markos Dintsios, J.-Matthias Graf von der Schulenburg, Volker E. Amelung, Jörg Ruof
Publikováno v:
Health Economics Review, Vol 8, Iss 1, Pp 1-11 (2018)
Abstract Background According to the AMNOG act, the German Federal Joint Committee (G-BA) determines the additional benefit of new medicines as a basis for subsequent price negotiations. Pharmaceutical companies may withdraw their medications from th
Externí odkaz:
https://doaj.org/article/b0233d39cbbf4519bd29290918586e0e
Autor:
Giovanni Giuliani, Frederic Chassagnol, David Traub, Marlene Gyldmark, Ansgar Hebborn, Pierre Ducournau, Jörg Ruof
Publikováno v:
Health Economics Review, Vol 8, Iss 1, Pp 1-11 (2018)
Abstract Background Health Technology Assessments (HTA) procedures differ substantially across the various European countries. We reviewed recent appraisals of a pharmaceutical manufacturer in three major European markets (France; Italy; Germany) and
Externí odkaz:
https://doaj.org/article/3954396c651349efa31857e995d62dc8
Publikováno v:
BMC Health Services Research, Vol 16, Iss 1, Pp 1-11 (2016)
Abstract Background Previous evaluations of oncological medicines in the German early benefit assessment (EBA) procedure have demonstrated inconsistent acceptance of endpoints by regulatory authorities and the Federal Joint Committee (G-BA). Accepted
Externí odkaz:
https://doaj.org/article/bd6a9ff0d0d24ff0a834862fc21cf9e7
Untersuchung der Akzeptanz und der Ablehnungsgründe indirekter Vergleiche in IQWiG-Nutzenbewertungen
Publikováno v:
Gesundheitsökonomie & Qualitätsmanagement. 25:24-36
Zusammenfassung Hintergrund/Fragestellung Seit dem Inkrafttreten des „Arzneimittelmarktneuordnungsgesetzes“ (AMNOG) 2011 bewertet der „Gemeinsame Bundesausschuss“ (GBA) unter regelhafter Einbindung des Instituts für Qualität und Wirtschaftl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5550a07ca5d7261276ad53b4692d72e3
https://doi.org/10.1055/a-0890-7985
https://doi.org/10.1055/a-0890-7985